Arrowhead Pharmaceuticals
ARWR
$21.87
Share price
-6.10%
Change (1 day)
-34.87%
Change (1 year)
Categories
Arrowhead Pharmaceuticals (ARWR) - Total debt
Total debt on the balance sheet as of December 2023 : $0.11 B
According to Arrowhead Pharmaceuticals 's latest financial reports the company's total debt is $0.11 B. A company’s total debt is the sum of all current and non-current debts.
Arrowhead Pharmaceuticals - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-09-30 | $0.11 B | 41.18% |
| 2022-09-30 | $81.57 M | 219.34% |
| 2021-09-30 | $25.54 M | 20.85% |
| 2020-09-30 | $21.13 M | |
| 2019-09-30 | $N/A | -100% |
| 2018-09-30 | $2.32 M | -8.23% |
| 2017-09-30 | $2.53 M | -7.12% |
| 2016-09-30 | $2.72 M | 259.7% |
| 2015-09-30 | $0.75 M | -25.82% |
| 2014-09-30 | $1.02 M | -55.63% |
| 2013-09-30 | $2.3 M | -5.44% |
| 2012-09-30 | $2.43 M | 301.57% |
| 2011-09-30 | $0.6 M | 21.36% |
| 2010-09-30 | $0.5 M | -59.23% |
| 2009-09-30 | $1.22 M | -20.2% |
| 2008-09-30 | $1.53 M | |
| 2002-09-30 | $0.63 M | 13.33% |
| 2001-09-30 | $0.55 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 24,636.46% | 🇺🇸 USA |
 Moderna
MRNA | $1.24 B | 948.26% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $6.16 M | -94.80% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $1.30 B | 1,000.87% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | $30.2 M | -74.52% | 🇺🇸 USA |